A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

Clinical trial NCT07521241 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07521241
Sponsor: Addpharma Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Liver Disease (CLD)

Start date: 2026-05-01
Primary completion: 2026-06-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.